# HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation

> **NCT05119777** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 140 (actual)

## Conditions studied

- Soft Tissue Augmentation

## Interventions

- **DEVICE:** HArmonyCa Injectable Gel

## Key facts

- **NCT ID:** NCT05119777
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-13
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05119777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05119777, "HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05119777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*